announces
-
Spine
InVivo Therapeutics Announces Topline Data from Pivotal INSPIRE 2.0 Study in Acute Spinal Cord Injury
Study did not achieve primary endpoint of defined improvement on standard impairment scaleInVivo to evaluate full data set and strategic…
Read More » -
Financial
Zimmer Biomet Announces Quarterly Dividend for First Quarter of 2023
WARSAW, Ind., March 8, 2023 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced…
Read More » -
Recon
Miach Orthopaedics Announces BEAR® Implant Distribution Agreement with Veteran’s Health Medical Supply
March 7, 2023 WESTBOROUGH, Mass.–(BUSINESS WIRE)–Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from…
Read More » -
Spine
Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor
Marks the eighth advisor to growing KOL program to build strong body of clinical evidence and support US commercialization Aclarion…
Read More » -
Extremities
Mediliant Group Announces New President of Their Facility in Plymouth, Indiana
Manufacturing expert, Jason Ratcliffe joins Mediliant’s leadership team as the organization continues to expand and exceed customer expectations. LE LOCLE,…
Read More » -
Financial
ATEC to Participate in Upcoming Investor Conferences
CARLSBAD, Calif., February 24, 2023–(BUSINESS WIRE)– Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the…
Read More » -
Financial
Paragon 28, Inc. Announces Closing of Underwriters’ Option to Purchase Additional Shares in Connection with Public Offering of Common Stock
February 17, 2023 ENGLEWOOD, Colo.–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) (“Paragon”), a leading medical device company exclusively focused on the…
Read More » -
Sports Medicine
Lazurite® Names Physicians to Medical Advisory Board
CLEVELAND– February 23, 2023 (BUSINESS WIRE)–Medical device and technology company Lazurite today announced that Laith Jazrawi, M.D. and Mark Schickendantz,…
Read More » -
Biologics
Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE™ PRFM
BIOINCYTE™ is a Next-Generation Autologous Fibrin and Platelet System HACKENSACK, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) — Royal Biologics, a…
Read More »